Juvenile idiopathic arthritis and rheumatoid arthritis are both inflammatory diseases that affect the joints, but they’re separate conditions with unique long-term outlooks. The most common type of ...

COPENHAGEN – Baricitinib (Olumiant), a Janus kinase (JAK) inhibitor, significantly increases time to disease flare and decreases frequency of flares in patients with juvenile idiopathic arthritis (JIA ...

Proper diagnosis and treatment are key when it comes to this autoimmune condition, the most common form of arthritis affecting children and teens. Clearing up misconceptions can help. The term ...

FRESNO, Calif. (KFSN) -- July is Juvenile Arthritis Awareness Month. Most think of it as a disease that only impacts older adults, but according to Central Valley doctors, there's a growing population ...

Please provide your email address to receive an email when new articles are posted on . Kevzara is approved for polyarticular JIA in patients weighing 63 kg or greater. The drug is an IL-6 inhibitor ...

Seven-year-old Kiana Knoespel lives with juvenile arthritis and advocates for others with the condition. Kiana and her family raise awareness and funds for the Arthritis Foundation. There is a ...

SAN ANTONIO – Nearly 90% of people surveyed by the Arthritis Foundation said they have pain that disrupts their daily activities. This reality is especially daunting for children, as hundreds of ...

ZIONSVILLE, Ind. (WISH) — A local teenager is raising awareness about juvenile arthritis and making headlines for raising money to find a cure. Cameron Miller, 15, has raised more than $24,000 to ...

Please provide your email address to receive an email when new articles are posted on . Juvenile arthritis can impact the physical and emotional wellbeing of children in unique ways, manifesting in ...

Juvenile Idiopathic Arthritis Pipeline Insight – 2025 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, ...